Disease Info Card

Pulmonary Hypertension

Information about Pulmonary Hypertension: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Pulmonary Hypertension

Most recent studies have shown that Pulmonary Hypertension shares some biological mechanisms with anoxia, chronic-pulmonary-heart-disease, congenital-heart-defects, dyspnea, fibrosis, heart-diseases, heart-failure, heart-septal-defects, hypertensive-disease, hypertrophy, hypoxia, idiopathic-pulmonary-hypertension, lung-diseases, lung-diseases-obstructive, pathologic-vasoconstriction, pulmonary-embolism, right-ventricular-failure, right-ventricular-hypertrophy, stenosis, vascular-diseases.

Among the many pathways, these few ones have gauged particular interests from scientists studying Pulmonary Hypertension, and have been seen in publications frequently: Angiogenesis, Cell Growth, Cell Proliferation, Coagulation, Inflammatory Response, Localization, Lung Development, Lung Growth, Muscle Cell Proliferation, Pathogenesis, Platelet Activation, Platelet Aggregation, Reflex, Response To Hypoxia, Secretion, Smooth Muscle Cell Proliferation, Transport, Transposition, Vasoconstriction, Vasodilation

Quite a number of genes have been found to play important roles in Pulmonary Hypertension, such as AMY2A, ASAP1, ASAP2, BLOC1S6, EDN1, EPB42, MCAT, MRPS30, NOS3, PAH, PAPOLA, PDAP1, PRH1, PVR, REG3A, TUSC2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.